top of page
Events
Canurta Therapeutics at the 35th International Symposium on ALS/MND
Showcasing Innovative Research on ALS On December 7, 2024, Canurta Therapeutics attended the 35th International Symposium on ALS/MND,...
Jan 22, 2025
3-Minute Pitch at ACT Canada Consortium: Advancing ALS Treatment with CNR-401
Canurta Therapeutics is pleased to share that CEO Akeem Gardner participated in the ACT (Accelerating Clinical Trials) Canada Consortium...
Oct 10, 2024
Reflecting on the ALS Drug Development Summit in Boston
This week, I had the opportunity to attend the ALS Drug Development Summit in Boston, an event that brought together the brightest minds...
May 24, 2024
bottom of page